Keywords: ANCOVA; analysis of covariance; CVD; cardiovascular disease; CPMP; Committee for Proprietary Medicinal Products; cLDA; constrained longitudinal model; VA; Department of Veterans Affairs; EHR; electronic health records; FFQ; Food Frequency Questionnaire; F
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: α-AASA; α-amino adipic semialdehyde; cPMP; cyclic pyranopterin monophosphate; HIE; hypoxic ischemic encephalopathy; Moco; molybdenum cofactor; MoCD; molybdenum cofactor deficiency; Molybdenum cofactor deficiency; Cyclic PMP; Neonatal seizures; S-sulfocy
Keywords: CMC; Regulatory; Cell therapy; CAT; Committee for Advanced Therapies; CCIT; container closure integrity test; CFR; Code of Federal Regulations; CLIA; Clinical Laboratory Improvement Amendments; CMC; Chemistry Manufacturing and Controls; CPMP; Committee fo
Identification of a protein-protein interaction network downstream of molybdenum cofactor biosynthesis in Arabidopsis thaliana
Keywords: ABA3; Moco sulfurase; AO; aldehyde oxidase; BiFC; bimolecular fluorescence complementation assay; CLUC; C-terminal half of the reporter protein luciferase; CNX; cofactor for nitrate reductase and xanthine dehydrogenase; cPMP; cyclic pyranopterin monophosp
The molybdenum cofactor biosynthesis complex interacts with actin filaments via molybdenum insertase Cnx1 as anchor protein in Arabidopsis thaliana
Keywords: ABD2; actin binding domain 2; AO; aldehyde oxidase; BiFC; bimolecular fluorescence complementation; CKL6; casein-kinase-1-like; CLuc; C-terminus of the luciferase; Cnx; cofactor for nitrate reductase and xanthine dehydrogenase; cPMP; cyclic pyranopterin m
Devices for intradermal vaccination
Keywords: WHO; World Health Organisation; EMA; European Medicines Agency; CDSN device; Convergent-divergent supersonic nozzle device; CST devices; Contoured shock tube device; PMED; Particle-mediated epidermal delivery; EPI; Epidermal powder immunisation; CPMP; C
Development and performance of a new hydrofluoroalkane (HFA 134a)-based metered dose inhaler (MDI) of salmeterol
Keywords: Metered dose inhaler; Bronchodilator; Salmeterol; Hydrofluoroalkane HFA; Particle size distribution; Dose uniformity; BOU; beginning of use; CFC; chlorofluorocarbon; CPMP; Committee for Proprietary Medicinal Products; ECD; effective cut-off diameter; EOU;